Dr. Charles Link recently discussed the innovative SYNC-T technology (Syncromune® Inc.) during a phase one trial targeting hormone-refractory prostate cancer—a…
Browsing: Prostate
… [VIDEO & SLIDES] Alex Chehrazi –Raffle, MD, City of Hope – 2024 MOASC Annual Oncology Summit & Research Symposium…
By. Tyler Ames, PhDDate. November 01, 2023Tyler Ames, Ph.D. in oncology research, delves into the intricate mechanisms of PT-112’s impact…
Author: Dr. Oliver Sartor (on-camera comments) – Courtesy of ESMO.org At ESMO 2023, an opportunity arose to present new data…
By: Neal Shore, MD Date: October 25, 2023 In the abstract describing the EMBARK Phase 3 trial, Dr. Neal Shore…
Jalen Patel, MD – City of Hopeaugust 21, 2023Drawing from data provided by ASCO and Friends of Cancer Research, the…
Welcome to our in-depth exploration of a topic of big importance in the field of oncology: Metastatic Castration-Resistant Prostate Cancer…
Jonathan David Tward ,MD, PHD, FASTRO – University of Utah A study using the Prolaris test shows that it can…
Scott T Tagawa, MD, MS, FASCO, FACP – Weill Cornell This study explores the use of a combination therapy, involving…
Prof. Arun Azad, MBBS, PhD from the Peter MacCallum Cancer Centre, has recently conducted a Phase 3 clinical trial called…
CAR T-cell: Advances in Adoptive Therapies for Targeting Heterogeneity in mCRPC Lupita Lopez By Lupita Lopez, BS Ph.D. candidate at…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an…
For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an…
For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an…
For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an…
For this series, Dr. Kwon discusses the decision-making process with Fred, who has recurrent prostate cancer and is making an…
iFrame is not supported! MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022] Which is Better: CT…
MIRAGE Trial Phase 3: CT / MRI SBRT Which is Better? [2022] Which is Better: CT or MRI SBRT in…
iFrame is not supported! Cribriform CAP Intraductal Carcinoma Prostate [2022] Cribriform Prostate Cancer Clinical Trial I’m here to talk…
Cribriform CAP Intraductal Carcinoma Prostate [2022] Cribriform Prostate Cancer Clinical Trial I’m here to talk about our recent study,…
DASL-HiCaP Phase 3 Trial [2022]: Update David Wise MD Â David Wise, MD Spoke with OncologyTube about the DASL-HiCaP (randomised)…
Lutetium-177–PSMA-617 [2022]: Update David Wise MD  So Lutetium-PSMA-617 ((lu psma 617) prostate specific membrane antigen), we’ll call it 617…
ASCO 2022 Prostate Cancer Overview: MOASC Spotlight  ARASENS Trial I presented at MOASC three datasets in prostate cancer from…
Are you aware that Black men continue to suffer worse outcomes compared to White men with prostate cancer? Through this…
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…
Dr. Daniel Kwon, one of the participants in this past year’s GRACE Patient Education Ambassador Program, produced this great video…
This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…
This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the…
This educational activity features a panel consisting of an oncologist as well as leading experts (a urologist and a researcher)…
Abhishek Tripathi, MD, Assistant Professor of Medicine in the section of Hematology/Oncology at the University Of Oklahoma Health Sciences Center.…
Abhishek Tripathi, MD, Assistant Professor of Medicine in the section of Hematology/Oncology at the University Of Oklahoma Health Sciences Center.…
Howard M. Sandler, MD, Ronald H. Bloom Family Chair, Cancer Therapeutics, Chair, Department of Radiation Oncology, Professor, Radiation Oncology at…
Howard M. Sandler, MD, Ronald H. Bloom Family Chair, Cancer Therapeutics, Chair, Department of Radiation Oncology, Professor, Radiation Oncology at…
Spyridon Basourakos, MD, Urology Resident 5th year at Weill Cornell Medicine, Jonathan E. Shoag, MD, Adjunct Clinical Assistant Professor of…
Spyridon Basourakos, MD, Urology Resident 5th year at Weill Cornell Medicine, Jonathan E. Shoag, MD, Adjunct Clinical Assistant Professor of…
Neeraj Agarwal, MD, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI),…
Neeraj Agarwal, MD, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI),…
Sanika Bodas, Ph.D., Ph.D. Student at University of Nebraska Medical Center. In this video, she speaks about the AACR 2022…
Sanika Bodas, Ph.D., Ph.D. Student at University of Nebraska Medical Center. In this video, she speaks about the AACR 2022…
Linda Kachuri, PhD, Postdoctoral Scholar, Epidemiology & Biostatistics at UC San Francisco. In this video, she speaks about the AACR…
Alberto Anel, Ph.D., Professor of Biochemistry, Department of Biochemistry and Molecular and Cellular Biology, Biochemistry and Molecular Biology Area, Science…
Alberto Anel, Ph.D., Professor of Biochemistry, Department of Biochemistry and Molecular and Cellular Biology, Biochemistry and Molecular Biology Area, Science…
Kim Chi, MD, Vice President & Chief Medical Officer of BC Cancer speaks about TITAN: A final analysis with close…
Kim Chi, MD, Vice President & Chief Medical Officer of BC Cancer speaks about TITAN: A final analysis with close…
Professor Fred Saad, MD, FRCS, Professor, and Chairman of Urology and Director of Genitourinary Oncology at the University of Montreal…
Professor Fred Saad, MD, FRCS, Professor, and Chairman of Urology and Director of Genitourinary Oncology at the University of Montreal…
Alicia K. Morgans, MD, MPH, Genitourinary Medical Oncologist, Medical Director of Survivorship Program Dana-Farber Cancer Institute. In this video, she…
Alicia K. Morgans, MD, MPH, Genitourinary Medical Oncologist, Medical Director of Survivorship Program Dana-Farber Cancer Institute. In this video, she…